A novel immunotherapy to treat HCV infection. [ 2009 - 2012 ]

Research Grant

Researchers: Prof Eric Gowans (Principal investigator) ,  A/Pr Bruce Loveland ,  Prof Stuart Roberts

Brief description It is possible to cure some patients with HCV infection but the current therapy is very costly and produces numerous side effects in treated individuals. We propose to treat patients using a new therapy in which HCV proteins are first expressed in blood cells ex vivo and the cells then manipulated to generate dying cells. These will be injected into the same patient from which they were collected initially and are expected to elicit high levels of HCV immunity with the potential for cure.

Funding Amount $AUD 568,088.47

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant